Benitec Biopharma (BNTC) Return on Capital Employed: 2020-2025
Historic Return on Capital Employed for Benitec Biopharma (BNTC) over the last 4 years, with Mar 2025 value amounting to -0.44%.
- Benitec Biopharma's Return on Capital Employed rose 102.00% to -0.44% in Q1 2025 from the same period last year, while for Mar 2025 it was -0.44%, marking a year-over-year increase of 102.00%. This contributed to the annual value of -0.96% for FY2024, which is 1442.00% up from last year.
- Per Benitec Biopharma's latest filing, its Return on Capital Employed stood at -0.44% for Q1 2025, which was down 18.66% from -0.37% recorded in Q4 2024.
- Over the past 5 years, Benitec Biopharma's Return on Capital Employed peaked at -0.37% during Q4 2024, and registered a low of -8.07% during Q2 2023.
- Moreover, its 3-year median value for Return on Capital Employed was -1.18% (2023), whereas its average is -1.92%.
- Per our database at Business Quant, Benitec Biopharma's Return on Capital Employed slumped by 482bps in 2023 and then skyrocketed by 729bps in 2024.
- Over the past 5 years, Benitec Biopharma's Return on Capital Employed (Quarterly) stood at -1.29% in 2021, then dropped by 18bps to -1.47% in 2022, then climbed by 29bps to -1.18% in 2023, then surged by 80bps to -0.37% in 2024, then soared by 102bps to -0.44% in 2025.
- Its Return on Capital Employed stands at -0.44% for Q1 2025, versus -0.37% for Q4 2024 and -0.40% for Q3 2024.